AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2004
Jan 12, 2004
29875_dirs_2004-01-12_65ecd840-f0e2-4cd1-bfed-4f9fa913e1e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CORP (CVS)
CIK: 0000064803
Period of Report: 2004-01-08
Reporting Person: RYAN THOMAS M (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-01-08 | Common Stock (Restricted) | A | 75000 | — | Acquired | 314208 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-01-08 | Stock Option | $35.335 | A | 200000 | Acquired | 2011-01-08 | Common Stock (200000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $16.1811 | 2005-04-11 | Common Stock (123230) | 123230 | Direct |
| Stock Option | $16.7223 | 2006-04-14 | Common Stock (392920) | 392920 | Direct |
| Stock Option | $23 | 2007-02-17 | Common Stock (391320) | 391320 | Direct |
| Stock Option | $25.125 | 2013-01-09 | Common Stock (450000) | 450000 | Direct |
| Stock Option | $29.925 | 2012-01-02 | Common Stock (506062) | 506062 | Direct |
| Stock Option | $36.6953 | 2008-02-27 | Common Stock (195660) | 195660 | Direct |
| Stock Option | $37.3125 | 2008-03-12 | Common Stock (600000) | 600000 | Direct |
| Stock Option | $38.5625 | 2010-01-03 | Common Stock (200000) | 200000 | Direct |
| Stock Option | $50 | 2009-03-10 | Common Stock (150000) | 150000 | Direct |
| Stock Option | $60.525 | 2011-03-07 | Common Stock (250000) | 250000 | Direct |
Footnotes
F1: Options become exercisable in three equal annual installments, commencing 01/08/2005.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3